histone deacetylase inhibitors
HDIs and oncology’s great hope 10/12/2008 10:30:00
Histone deacetylase inhibitors (HDIs) have emerged as oncology’s Great Hope – rarely has a new class of drugs showed promise against such a broad range of cancers, including leukaemias, lymphomas and solid tumours.Histone deacetylase inhibitors (HDIs) have emerged as oncology’s Great Hope – rarely has a new class of drugs showed promise against such a broad range of cancers, including leukaemias, lymphomas and solid tumours.
